Diabetic patients with chronic kidney disease may benefit more from GLP-1 analogue treatment

Media formats available:

Management of hyperkalemia in CKD and HFrEF
Management of hyperkalemia in CKD and HFrEF
Kidney Disease
Management of hyperkalemia in CKD and HFrEF
- George L. Bakris, MD
- David Bushinsky, MD
- Lars Lund, MD
A multidisciplinary approach to managing potassium levels in patients with HF when optimizing RAASi therapy
A multidisciplinary approach to managing potassium levels in patients with HF when optimizing RAASi therapy
Kidney Disease
A multidisciplinary approach to managing potassium levels in patients with HF when optimizing RAASi therapy
- Antoni Bayés-Genís, MD, PhD
- Patrick Rossignol, MD, PhD
The key role of RAASi therapy in patients with HF
The key role of RAASi therapy in patients with HF
Tackling the risk of hyperkalemia through guideline-recommended heart failure therapy
The key role of RAASi therapy in patients with HF
- Shelley Zieroth, MD
Effect of SGLT2i on diuretic efficacy in acute heart failure
Effect of SGLT2i on diuretic efficacy in acute heart failure
ESC Congress 2023
Effect of SGLT2i on diuretic efficacy in acute heart failure

PACE-CME